FEDERAL · 2026-18430
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease
SEP 10, 2026Health & safety
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease. Issued by Health and Human Services Department, Food and Drug Administration.
What changes
Health & safety
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease
Timeline
Published September 10, 2026
Takes effect September 10, 2026
Official text
Source: U.S. Federal Register (public domain) · View the official text ↗. The effective date comes from the official document; confirm on the source.